Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Proteogenomics Coupled with Ex Vivo Profiling for Therapeutic Targeting in AML

Heather C Murray, Anoop K Enjeti, Saumya Samaraweera, Joshua S Brzozowski, Kasey Miller, Richard J D'Andrea, Nicole M Verrills

Blood (2023) 142 (Supplement 1): 4300.

https://doi.org/10.1182/blood-2023-191314

Published: 2023

Journal Articles

Preclinical Evaluation of Bisantrene As Single Agent and in Combination with Decitabine for Acute Myeloid Leukemia

Nicole M Verrills, Heather C Murray, Joshua S Brzozowski, Nikita Panicker, Kasey Miller, Marinella Messina, Benjamin J Buckley, Michael J Kelso, Anoop K Enjeti

Blood (2023) 142 (Supplement 1): 5773.

https://doi.org/10.1182/blood-2023-188353

Published: 2023

Journal Articles

Highly Efficient Multiplexed Base Editing with Minimized Off-Targets for the Development of Universal CAR-T Cells to Treat Pediatric T-ALL

Jason M Gehrke, PhD, Aaron Edwards, MS, Ryan C. Murray, MS, Amy Shaw, MS, Yeh-Chuin Poh, PhD, Sarah Smith, Yi Yu, PhD, Nicole M. Gaudelli, PhD, Waseem Qasim, MBBS, PhD, Giuseppe Ciaramella, PhD, B.Sc.

Blood (2019) 134 (Supplement_1): 5127.

https://doi.org/10.1182/blood-2019-130562

Published: 2019

Journal Articles

A Novel TGF-β 2 /Interleukin Receptor Signal Conversion Platform That Protects CAR/TCR T Cells from TGF-β 2 -Mediated Immune Suppression and Induces T Cell Supportive Signaling Networks

Benjamin Boyerinas, Sara M. Miller, Ryan C. Murray, John W. Evans, Geoffrey B. Parsons, Katherine J. Seidl, Kevin M. Friedman, Richard A. Morgan, PhD

Blood (2017) 130 (Supplement 1): 1911.

https://doi.org/10.1182/blood.V130.Suppl_1.1911.1911

Published: 2017

Journal Articles

Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis

Janis L. Abkowitz, Gerard Schaison, Farid Boulad, Deborah L. Brown, George R. Buchanan, Christine A. Johnson, Jeffrey C. Murray, Kathleen M. Sabo

Blood (2002) 100 (8): 2687–2690.

https://doi.org/10.1182/blood.V100.8.2687

Published: 2002

Journal Articles

Recombinant interleukin-2 infusions and decreased IgG2 subclass concentrations [see comments]

RJ Soiffer, C Murray, J Ritz, N Phillips, D Jacobsohn, S Chartier, DM Ambrosino

Blood (1995) 85 (4): 925–928.

https://doi.org/10.1182/blood.V85.4.925.bloodjournal854925

Published: 1995

Journal Articles

Effect of low-dose interleukin-2 on disease relapse after T-cell- depleted allogeneic bone marrow transplantation

RJ Soiffer, C Murray, R Gonin, J Ritz

Blood (1994) 84 (3): 964–971.

https://doi.org/10.1182/blood.V84.3.964.964

Published: 1994

Journal Articles

Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies

RJ Soiffer, MJ Robertson, C Murray, K Cochran, J Ritz

Blood (1993) 82 (9): 2790–2796.

https://doi.org/10.1182/blood.V82.9.2790.2790

Published: 1993

Journal Articles

Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma

KC Anderson, J Andersen, R Soiffer, AS Freedman, SN Rabinowe, MJ Robertson, N Spector, K Blake, C Murray, A Freeman

Blood (1993) 82 (8): 2568–2576.

https://doi.org/10.1182/blood.V82.8.2568.2568

Published: 1993

Journal Articles

Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation

RJ Soiffer, R Gonin, C Murray, MJ Robertson, K Cochran, S Chartier, C Cameron, J Daley, H Levine, LM Nadler

Blood (1993) 82 (7): 2216–2223.

https://doi.org/10.1182/blood.V82.7.2216.2216

Published: 1993

Journal Articles

Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia

MJ Robertson, RJ Soiffer, AS Freedman, SL Rabinowe, KC Anderson, TJ Ervin, C Murray, K Dear, JD Griffin, LM Nadler

Blood (1992) 79 (9): 2229–2236.

https://doi.org/10.1182/blood.V79.9.2229.2229

Published: 1992

Journal Articles

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation

RJ Soiffer, C Murray, K Cochran, C Cameron, E Wang, PW Schow, JF Daley, J Ritz

Blood (1992) 79 (2): 517–526.

https://doi.org/10.1182/blood.V79.2.517.517

Published: 1992

Journal Articles

Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation

RJ Soiffer, L Bosserman, C Murray, K Cochran, J Daley, J Ritz

Blood (1990) 75 (10): 2076–2084.

https://doi.org/10.1182/blood.V75.10.2076.2076

Published: 1990

Journal Articles

Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium

DC Roy, R Tantravahi, C Murray, K Dear, B Gorgone, KC Anderson, AS Freedman, LM Nadler, J Ritz

Blood (1990) 75 (1): 296–304.

https://doi.org/10.1182/blood.V75.1.296.296

Published: 1990

Journal Articles

Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation

RG Knowlton, VA Brown, JC Braman, D Barker, JW Schumm, C Murray, T Takvorian, J Ritz, H Donis-Keller

Blood (1986) 68 (2): 378–385.

https://doi.org/10.1182/blood.V68.2.378.378

Published: 1986

Journal Articles

Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation

T Hercend, T Takvorian, A Nowill, R Tantravahi, P Moingeon, KC Anderson, C Murray, C Bohuon, A Ythier, J Ritz

Blood (1986) 67 (3): 722–728.

https://doi.org/10.1182/blood.V67.3.722.722

Published: 1986

Journal Articles

THE ACTION OF PTEROYL GLUTAMIC ACID AND NATURAL SOURCES OF FOLIC ACID ON BLOOD DYSCRASIAS INDUCED BY SULFONAMIDE DRUGS

H. G. PETERING, PH.D., R. A. DELOR, B.S., H. C. MURRAY, PH.D

Blood (1947) 2 (5): 440–450.

https://doi.org/10.1182/blood.V2.5.440.440

Published: 1947

NARROW

Proteogenomics Coupled with Ex Vivo Profiling for Therapeutic Targeting in AML

Preclinical Evaluation of Bisantrene As Single Agent and in Combination with Decitabine for Acute Myeloid Leukemia

Highly Efficient Multiplexed Base Editing with Minimized Off-Targets for the Development of Universal CAR-T Cells to Treat Pediatric T-ALL

A Novel TGF-β 2 /Interleukin Receptor Signal Conversion Platform That Protects CAR/TCR T Cells from TGF-β 2 -Mediated Immune Suppression and Induces T Cell Supportive Signaling Networks

Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis

Recombinant interleukin-2 infusions and decreased IgG2 subclass concentrations [see comments]

Effect of low-dose interleukin-2 on disease relapse after T-cell- depleted allogeneic bone marrow transplantation

Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies

Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma

Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation

Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation

Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation

Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium

Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation

Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation

THE ACTION OF PTEROYL GLUTAMIC ACID AND NATURAL SOURCES OF FOLIC ACID ON BLOOD DYSCRASIAS INDUCED BY SULFONAMIDE DRUGS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only